Delayed Onset Muscle Soreness

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Lead Pharma
Lead PharmaNetherlands - Oss
1 program
1
Loxoprofen Pain PatchPhase 21 trial
Active Trials
NCT02602353CompletedEst. Dec 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Lead PharmaLoxoprofen Pain Patch

Clinical Trials (1)

NCT02602353Lead PharmaLoxoprofen Pain Patch

Pilot Study Comparing the Efficacy and Safety of a New Pain Patch and Placebo in Delayed Onset Muscle Soreness (DOMS)

Start: Oct 2015Est. completion: Dec 2015
Phase 2Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space